<DOC>
	<DOCNO>NCT02689882</DOCNO>
	<brief_summary>Nicotinamide riboside ( NR ) available counter nutraceutical ( NiagenÂ® , ChromaDex , Inc. ) since summer 2013 . However , classical pharmacokinetic ( PK ) data NR report human . This study use recently-developed , whole blood assay NR ass pharmacokinetics NR maximum dose 1000 mg twice daily , collect history , physical examination laboratory data determine safety tolerability NR eight , healthy volunteer . In addition , whole blood nicotinamide adenine dinucleotide ( NAD ) level measure time point , determine whether NR dose significantly raise whole blood NAD level .</brief_summary>
	<brief_title>`` Pharmacokinetic Study Nicotinamide Riboside ''</brief_title>
	<detailed_description>1 . On Day 1 , participant baseline assessment , include blood pressure heart rate , well baseline assessment `` safety '' lab : complete blood count white blood count differential platelet , serum chemistry panel ( sodium , potassium , chloride , glucose , blood urea nitrogen creatinine ) , uric acid , creatine kinase , aspartate aminotransferase alanine aminotransferase , lactate dehydrogenase . 2 . Participants receive 250 mg nicotinamide riboside ( NR ) mouth daily Days 1-2 , 250 mg NR mouth twice daily Days 3-4 , 500 mg NR twice daily mouth Days 5-6 1000 mg NR twice daily mouth Days 7-8 . 3 . On Day 2 , blood sample obtain participant measure serum chemistry panel ass possibility hyperkalemia hyperglycemia . In addition , instant read potassium measure use point-of-care device available University Washington ( UW ) General Clinical Research Center ( GCRC ) . If potassium great 5.5 , repeat value ECG perform Study Investigator . If great 6.0 , Study Investigator evaluate subject admission . 4 . On Day 9 prior receive morning dose , participant admit UW GCRC overnight stay . 1 . In UW GCRC , participant receive last 1000 mg dose NR time=0 . 2 . Blood sample collect time = 30 minute 1 , 2 , 3 , 4 , 6 , 8 , 12 , 16 24 hour . 3 . Whole blood sample freeze -80 degree C assay NR NAD+ . 4 . `` Safety lab '' perform Day 1 repeat</detailed_description>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Healthy , adult ( age 2150 year ) , male female Willing able provide inform consent Current smoking Receiving concurrent medication supplement History liver , renal , cardiovascular , endocrine , neurological disease Known allergy niacin nicotinamide ribosome Unwilling refrain drinking alcohol duration study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>nicotinamide riboside</keyword>
	<keyword>nicotinamide ribonucleoside</keyword>
	<keyword>Nicotinamide-Adenine Dinucleotide</keyword>
</DOC>